Hannah Brock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hannah Brock has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Anja Mehnert-Theuerkauf
Abt. für Medizinische Psychologie und Medizinische Soziologie, Universitätsklinikum Leipzig, Leipzig, Deutschland
7 shared publications Anja Mehnert-Theuerkauf
Department of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany (CCCG), University Medical Center Leipzig, Leipzig, Germany
5 shared publications- Annekathrin Sender
Department of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany (CCCG), University Medical Center Leipzig, Leipzig, Germany
5 shared publications Diana Richter
Department of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany (CCCG), University Medical Center Leipzig, Leipzig, Germany
5 shared publicationsMichael Friedrich
Department of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany (CCCG), University Medical Center Leipzig, Leipzig, Germany
5 shared publications- Michael Friedrich
Department of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany (CCCG), University Medical Center Leipzig, Leipzig, Germany
5 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 152 (9) , 185
Sleep quality and disturbances in adolescents and young adults with cancer compared to a healthy comparison group: results of the AYA-LE study
Purpose: Adolescents and young adults (AYAs) with cancer often exhibit riskier health behaviors, including poorer sleep patterns, compared to older individuals. Research on the relationship between cancer and sleep quality in AYA patients has yielded inconsistent results. This study investigates sleep quality in AYA patients compared to a healthy comparison group and examines associated sociodemographic, clinical, and psychosocial variables as well as physical activity. Methods: The prospective observational study included 407 AYA patients aged 18–39 years at diagnosis and 372 healthy participants aged 18–45 years, with data collected from May–September 2019. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Validated questionnaires measured self-efficacy, social support, anxiety, depression, quality of life, lack of energy, and physical activity. Multiple regression analyses were employed to explore the variables associated with sleep quality. Results: The mean age of the AYA patients was 34.8 years (75.2% women) and 32.3 years of the healthy participants (61.8% women). AYA patients demonstrated significantly poorer subjective sleep quality (d=0.31), lower sleep efficiency (d=0.15), more frequent sleep disturbances (d=0.23), greater use of sleep medication (d=0.25), and higher daytime dysfunction (d=0.29). Anxiety, depression (HADS), quality of life (EORTC), and unmet needs for support through lack of energy (SCNS) were significantly associated with PSQI (adjusted R 2 =0.35). Conclusion: These findings underscore the relevance of sleep disturbances in AYA patients and support greater attention to sleep disturbances in survivorship care. Routine assessment of sleep quality may help identify AYA patients who could benefit from further evaluation and appropriate support.
- 22 September 2026
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 152 (9) , 185
Open AccessSleep quality and disturbances in adolescents and young adults with cancer compared to a healthy comparison group: results of the AYA-LE study
Purpose: Adolescents and young adults (AYAs) with cancer often exhibit riskier health behaviors, including poorer sleep patterns, compared to older individuals. Research on the relationship between cancer and sleep quality in AYA patients has yielded inconsistent results. This study investigates sleep quality in AYA patients compared to a healthy comparison group and examines associated sociodemographic, clinical, and psychosocial variables as well as physical activity. Methods: The prospective observational study included 407 AYA patients aged 18–39 years at diagnosis and 372 healthy participants aged 18–45 years, with data collected from May–September 2019. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Validated questionnaires measured self-efficacy, social support, anxiety, depression, quality of life, lack of energy, and physical activity. Multiple regression analyses were employed to explore the variables associated with sleep quality. Results: The mean age of the AYA patients was 34.8 years (75.2% women) and 32.3 years of the healthy participants (61.8% women). AYA patients demonstrated significantly poorer subjective sleep quality (d=0.31), lower sleep efficiency (d=0.15), more frequent sleep disturbances (d=0.23), greater use of sleep medication (d=0.25), and higher daytime dysfunction (d=0.29). Anxiety, depression (HADS), quality of life (EORTC), and unmet needs for support through lack of energy (SCNS) were significantly associated with PSQI (adjusted R 2 =0.35). Conclusion: These findings underscore the relevance of sleep disturbances in AYA patients and support greater attention to sleep disturbances in survivorship care. Routine assessment of sleep quality may help identify AYA patients who could benefit from further evaluation and appropriate support.
- 21 August 2026
- Published by Springer Nature in Forum
- p. 1-4
Rückkehr ins Berufsleben bei jungen Erwachsenen (AYAs) mit einer Krebserkrankung
- 21 August 2026
- Published by Springer Nature in Forum
- p. 1-4
Rückkehr ins Berufsleben bei jungen Erwachsenen (AYAs) mit einer Krebserkrankung
- Open Access
- 7 April 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Long-term work ability, cognitive impairments and work-related concerns among young adult cancer survivors: a comparative analysis with healthy controls (AYA-LE study)
Background: Cancer can substantially disrupt the career paths of adolescent and young adult cancer survivors (AYA-CS). However, little is known about the long-term impact of cancer on their work life compared to healthy peers without a history of cancer. Methods: As part of the AYA-LE study, we surveyed AYA-CS (aged 18–39 years at time of diagnosis) and healthy controls (HC). A multivariate analysis of covariance (MANCOVA) was conducted to compare work ability (Work Ability Index), cognitive impairments (COPSOQ) and work-related concerns between groups, controlling for differences in age, gender and educational level. Predictors of work ability were analyzed on average 4 years after diagnosis (t3) using hierarchical regression analyses. Results: A total of 438 AYA-CS and 406 HC participated in the study. AYA-CS reported significantly lower work ability (M = 35.73 ± 0.35 vs. M = 39.17 ± 0.35; p < 0.001, ηp² = 0.06) and more severe cognitive impairment (M = 34.88 ± 1.08 vs. M = 29.15 ± 1.10; p < 0.001, ηp² = 0.02) than HC. They also reported more work-related concerns about reduced income, unemployment, limited career advancement and early retirement (all p < 0.001). In AYA-CS, lower work ability at t3 was associated with older age, metastatic or recurrent disease, more severe cognitive impairment, greater effort to cope with the disease, less employer support, and participation in rehabilitation measures (adj. R² = 0.59), with cognitive impairment and effort to cope with the disease emerging as the strongest predictors of work ability. Conclusions: AYA-CS continue to experience poorer work outcomes than their peers without cancer, even years after diagnosis. Our findings emphasize the need for early identification of at-risk survivors and for interventions addressing cognitive impairments, coping demands, and workplace support to sustain and improve work ability in this population.
- 7 April 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessLong-term work ability, cognitive impairments and work-related concerns among young adult cancer survivors: a comparative analysis with healthy controls (AYA-LE study)
Background: Cancer can substantially disrupt the career paths of adolescent and young adult cancer survivors (AYA-CS). However, little is known about the long-term impact of cancer on their work life compared to healthy peers without a history of cancer. Methods: As part of the AYA-LE study, we surveyed AYA-CS (aged 18–39 years at time of diagnosis) and healthy controls (HC). A multivariate analysis of covariance (MANCOVA) was conducted to compare work ability (Work Ability Index), cognitive impairments (COPSOQ) and work-related concerns between groups, controlling for differences in age, gender and educational level. Predictors of work ability were analyzed on average 4 years after diagnosis (t3) using hierarchical regression analyses. Results: A total of 438 AYA-CS and 406 HC participated in the study. AYA-CS reported significantly lower work ability (M = 35.73 ± 0.35 vs. M = 39.17 ± 0.35; p < 0.001, ηp² = 0.06) and more severe cognitive impairment (M = 34.88 ± 1.08 vs. M = 29.15 ± 1.10; p < 0.001, ηp² = 0.02) than HC. They also reported more work-related concerns about reduced income, unemployment, limited career advancement and early retirement (all p < 0.001). In AYA-CS, lower work ability at t3 was associated with older age, metastatic or recurrent disease, more severe cognitive impairment, greater effort to cope with the disease, less employer support, and participation in rehabilitation measures (adj. R² = 0.59), with cognitive impairment and effort to cope with the disease emerging as the strongest predictors of work ability. Conclusions: AYA-CS continue to experience poorer work outcomes than their peers without cancer, even years after diagnosis. Our findings emphasize the need for early identification of at-risk survivors and for interventions addressing cognitive impairments, coping demands, and workplace support to sustain and improve work ability in this population.
- 18 March 2026
- Published by Springer Nature in Forum
- Vol. 41 (3) , 231-233
Wirksamkeit eines digitalen Unterstützungsangebots in der onkologischen Routineversorgung
- 18 March 2026
- Published by Springer Nature in Forum
- Vol. 41 (3) , 231-233
Wirksamkeit eines digitalen Unterstützungsangebots in der onkologischen Routineversorgung
- Open Access
- 26 May 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-11
Peer2Me - impact of peer support on self-efficacy in young adult cancer survivors (YA-CS): findings from a comprehensive cohort design
Background: Numerous studies suggest that young adult cancer survivors (YA-CS) experience unmet needs regarding informational exchange about their disease and emotional support from peers. Currently, there is a lack of evaluated peer support interventions in Germany. This study aimed to evaluate the effectiveness of “Peer2Me”, a three-month one-to-one peer mentoring program, designed to improve self-efficacy among YA-CS. Methods: This study conducted a bi-center comprehensive cohort design and enrolled YA-CS (18–39 years old) undergoing acute treatment in Leipzig and Hamburg (Germany) across all tumour entities diagnosed within the last six months. YA-CS were allocated by preference to the intervention (IG, receiving peer mentoring) and comparison group (CG, care as usual). Following mentor training, tandems were matched by diagnosis, age, and gender. YA-CS completed questionnaires at baseline (t1), post-intervention (3 months later, t2) and three months post-intervention (t3). The primary outcome was self-efficacy measured with the Generalized Self-Efficacy Scale (GSES) and the Cancer Behaviour Inventory (CBI-B). Statistical analyses included mixed-design ANOVA and ANCOVA, controlling for baseline scores. Results: Out of 274 eligible YA-CS, a total of 106 YA-CS (IG: n = 77, CG: n = 29) completed the study. Two-thirds of YA-CS (66.7%) expressed a clear preference to be allocated to the IG. Baseline differences in coping behaviors were noted, with the IG demonstrating lower scores, suggesting a higher need for support. The ANCOVA revealed no group effects for the change of mean GSES scores from t1 to t2 (p =.897) or from t1 to t3 (p =.779). Also, no significant differences in the improvement of mean CBI-B scores between groups could be found from t1 to t2 (p =.903) or from t1 to t3 (p =.995). Conclusions: The “Peer2Me” program did not demonstrate a significant effect on improving self-efficacy among YA-CS during acute treatment. Although interest in peer mentoring was high, the intervention showed no measurable benefit in comparison with standard care. While the need for support was evident, further research is required to optimize peer interventions for this group. Trial registration: The study was retrospectively registered on February 4, 2022 at clinicaltrials.gov (NCT05336318).
- 26 May 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-11
Open AccessPeer2Me - impact of peer support on self-efficacy in young adult cancer survivors (YA-CS): findings from a comprehensive cohort design
Background: Numerous studies suggest that young adult cancer survivors (YA-CS) experience unmet needs regarding informational exchange about their disease and emotional support from peers. Currently, there is a lack of evaluated peer support interventions in Germany. This study aimed to evaluate the effectiveness of “Peer2Me”, a three-month one-to-one peer mentoring program, designed to improve self-efficacy among YA-CS. Methods: This study conducted a bi-center comprehensive cohort design and enrolled YA-CS (18–39 years old) undergoing acute treatment in Leipzig and Hamburg (Germany) across all tumour entities diagnosed within the last six months. YA-CS were allocated by preference to the intervention (IG, receiving peer mentoring) and comparison group (CG, care as usual). Following mentor training, tandems were matched by diagnosis, age, and gender. YA-CS completed questionnaires at baseline (t1), post-intervention (3 months later, t2) and three months post-intervention (t3). The primary outcome was self-efficacy measured with the Generalized Self-Efficacy Scale (GSES) and the Cancer Behaviour Inventory (CBI-B). Statistical analyses included mixed-design ANOVA and ANCOVA, controlling for baseline scores. Results: Out of 274 eligible YA-CS, a total of 106 YA-CS (IG: n = 77, CG: n = 29) completed the study. Two-thirds of YA-CS (66.7%) expressed a clear preference to be allocated to the IG. Baseline differences in coping behaviors were noted, with the IG demonstrating lower scores, suggesting a higher need for support. The ANCOVA revealed no group effects for the change of mean GSES scores from t1 to t2 (p =.897) or from t1 to t3 (p =.779). Also, no significant differences in the improvement of mean CBI-B scores between groups could be found from t1 to t2 (p =.903) or from t1 to t3 (p =.995). Conclusions: The “Peer2Me” program did not demonstrate a significant effect on improving self-efficacy among YA-CS during acute treatment. Although interest in peer mentoring was high, the intervention showed no measurable benefit in comparison with standard care. While the need for support was evident, further research is required to optimize peer interventions for this group. Trial registration: The study was retrospectively registered on February 4, 2022 at clinicaltrials.gov (NCT05336318).
- Open Access
- 21 January 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 96-104
Exploring how attachment insecurities mediate the link between sexual and partnership satisfaction in adolescents and young adults with cancer
Background and purpose: Comprehensive data on factors affecting partnership satisfaction among adolescents and young adult (AYA) cancer survivors are limited. Our study examines partnership satisfaction, sexual satisfaction, and attachment insecurities, exploring how attachment-related anxiety and avoidance influence the relationship between sexual and partnership satisfaction across major tumor entities in this population. Patients and methods: We utilized data from two measurement time points (t1 and t6) of the AYA-LE study, a prospective longitudinal investigation examining the temporal course and associated factors of life satisfaction and psychological distress among AYA cancer survivors. We examined the mediating effect of attachment insecurities (ECR-RD) on the relationship between sexual satisfaction (FLZ-Sex) and partnership satisfaction (PFB), while controlling for sociodemographic and clinical characteristics, in a sample of N = 275 participants. Results: Higher sexual satisfaction was correlated with lower attachment-related anxiety (r = -0.51, p < 0.001) and lower attachment-related avoidance (r = -0.49, p < 0.001). Both lower attachment-related anxiety and attachment-related avoidance were correlated with higher partnership satisfaction (r = -0.64, p < 0.001 and r = -0.72, p < 0.001, respectively). Sexual satisfaction partially predicted partnership satisfaction of AYA cancer survivors through attachment-related anxiety and attachment-related avoidance while the mediating effect accounted for 75% of the total effect. Interpretation: The associations between sexual satisfaction, partnership satisfaction, and attachment highlight the need to address emotional and relational aspects in supportive care for AYA cancer survivors. There is a clear need for more targeted studies on attachment patterns, sexual satisfaction, and partnership satisfaction in this specific population to further refine and validate these approaches.
- 21 January 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 96-104
Open AccessExploring how attachment insecurities mediate the link between sexual and partnership satisfaction in adolescents and young adults with cancer
Background and purpose: Comprehensive data on factors affecting partnership satisfaction among adolescents and young adult (AYA) cancer survivors are limited. Our study examines partnership satisfaction, sexual satisfaction, and attachment insecurities, exploring how attachment-related anxiety and avoidance influence the relationship between sexual and partnership satisfaction across major tumor entities in this population. Patients and methods: We utilized data from two measurement time points (t1 and t6) of the AYA-LE study, a prospective longitudinal investigation examining the temporal course and associated factors of life satisfaction and psychological distress among AYA cancer survivors. We examined the mediating effect of attachment insecurities (ECR-RD) on the relationship between sexual satisfaction (FLZ-Sex) and partnership satisfaction (PFB), while controlling for sociodemographic and clinical characteristics, in a sample of N = 275 participants. Results: Higher sexual satisfaction was correlated with lower attachment-related anxiety (r = -0.51, p < 0.001) and lower attachment-related avoidance (r = -0.49, p < 0.001). Both lower attachment-related anxiety and attachment-related avoidance were correlated with higher partnership satisfaction (r = -0.64, p < 0.001 and r = -0.72, p < 0.001, respectively). Sexual satisfaction partially predicted partnership satisfaction of AYA cancer survivors through attachment-related anxiety and attachment-related avoidance while the mediating effect accounted for 75% of the total effect. Interpretation: The associations between sexual satisfaction, partnership satisfaction, and attachment highlight the need to address emotional and relational aspects in supportive care for AYA cancer survivors. There is a clear need for more targeted studies on attachment patterns, sexual satisfaction, and partnership satisfaction in this specific population to further refine and validate these approaches.
- Open Access
- 26 December 2024
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 151 (1) , 1-11
Occupational adjustments and work ability of young adult cancer survivors: results from the AYA-Leipzig study
Purpose: Adolescent and young adult cancer survivors (AYA-CS) face a long working life after treatment, yet factors related to a successful return to work remain largely unexplored. We therefore aimed to investigate the use of occupational adjustments and their impact on work ability upon return to work. Methods: As part of the AYA-LE study, we surveyed AYA-CS (aged 18–39 at diagnosis) who returned to work and assessed work ability (Work Ability Index) as well as use and benefit of occupational adjustments. We analyzed predictors of use and benefit of occupational adjustments on average 4 years post-diagnosis using multivariate linear and logistic regression. Results: Out of 438 AYA-CS, 389 (88.8%) returned to work after cancer diagnosis and were included in analyses. Mean work ability was M = 36.2 (SD = 6.9), 11.4% reported poor, 34.7% moderate, 41.4% good and 12.5% excellent work ability. Following treatment, 82.3% used occupational adjustments, most frequently: flexible working hours, gradual reintegration and reduced working hours. The probability of a reduction in working hours was found to be higher among older AYA-CS (≥ 30), female gender and with a fatigue index ≥ 11 (R2 = 0.073). A fatigue index < 11, elevated levels of pain and the presence of metastases/recurrence were associated with a lower benefit of reduced working hours (R2 = 0.183). Younger age (< 30) and stem cell transplant were associated with a lower benefit of support from colleagues (R2 = 0.077). Conclusion: Our results highlight the need for targeted occupational counselling throughout the treatment and even beyond the return-to-work process, considering individual and social factors.
- 26 December 2024
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 151 (1) , 1-11
Open AccessOccupational adjustments and work ability of young adult cancer survivors: results from the AYA-Leipzig study
Purpose: Adolescent and young adult cancer survivors (AYA-CS) face a long working life after treatment, yet factors related to a successful return to work remain largely unexplored. We therefore aimed to investigate the use of occupational adjustments and their impact on work ability upon return to work. Methods: As part of the AYA-LE study, we surveyed AYA-CS (aged 18–39 at diagnosis) who returned to work and assessed work ability (Work Ability Index) as well as use and benefit of occupational adjustments. We analyzed predictors of use and benefit of occupational adjustments on average 4 years post-diagnosis using multivariate linear and logistic regression. Results: Out of 438 AYA-CS, 389 (88.8%) returned to work after cancer diagnosis and were included in analyses. Mean work ability was M = 36.2 (SD = 6.9), 11.4% reported poor, 34.7% moderate, 41.4% good and 12.5% excellent work ability. Following treatment, 82.3% used occupational adjustments, most frequently: flexible working hours, gradual reintegration and reduced working hours. The probability of a reduction in working hours was found to be higher among older AYA-CS (≥ 30), female gender and with a fatigue index ≥ 11 (R2 = 0.073). A fatigue index < 11, elevated levels of pain and the presence of metastases/recurrence were associated with a lower benefit of reduced working hours (R2 = 0.183). Younger age (< 30) and stem cell transplant were associated with a lower benefit of support from colleagues (R2 = 0.077). Conclusion: Our results highlight the need for targeted occupational counselling throughout the treatment and even beyond the return-to-work process, considering individual and social factors.
- Open Access
- 25 April 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e51949
Digital Therapeutic (Mika) Targeting Distress in Patients With Cancer: Results From a Nationwide Waitlist Randomized Controlled Trial
Background: Distress is highly prevalent among patients with cancer, but supportive care needs often go unmet. Digital therapeutics hold the potential to overcome barriers in cancer care and improve health outcomes. Objective: This study conducted a randomized controlled trial to investigate the efficacy of Mika, an app-based digital therapeutic designed to reduce distress across the cancer trajectory. Methods: This nationwide waitlist randomized controlled trial in Germany enrolled patients with cancer across all tumor entities diagnosed within the last 5 years. Participants were randomized into the intervention (Mika plus usual care) and control (usual care alone) groups. The participants completed web-based assessments at baseline and at 2, 6, and 12 weeks. The primary outcome was the change in distress from baseline to week 12, as measured by the National Comprehensive Cancer Network Distress Thermometer. Secondary outcomes included depression, anxiety (Hospital Anxiety and Depression Scale), fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue), and quality of life (Clinical Global Impression-Improvement Scale). Intention-to-treat and per-protocol analyses were performed. Analyses of covariance were used to test for outcome changes over time between the groups, controlling for baseline. Results: A total of 218 patients (intervention: n=99 and control: n=119) were included in the intention-to-treat analysis. Compared with the control group, the intervention group reported greater reductions in distress (P=.03; ηp²=0.02), depression (P<.001; ηp²=0.07), anxiety (P=.03; ηp²=0.02), and fatigue (P=.04; ηp²=0.02). Per-protocol analyses revealed more pronounced treatment effects, with the exception of fatigue. No group difference was found for quality of life. Conclusions: Mika effectively diminished distress in patients with cancer. As a digital therapeutic solution, Mika offers accessible, tailored psychosocial and self-management support to address the unmet needs in cancer care. Trial Registration: German Clinical Trials Register (DRKS) DRKS00026038; https://drks.de/search/en/trial/DRKS00026038
- 25 April 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e51949
Open AccessDigital Therapeutic (Mika) Targeting Distress in Patients With Cancer: Results From a Nationwide Waitlist Randomized Controlled Trial
Background: Distress is highly prevalent among patients with cancer, but supportive care needs often go unmet. Digital therapeutics hold the potential to overcome barriers in cancer care and improve health outcomes. Objective: This study conducted a randomized controlled trial to investigate the efficacy of Mika, an app-based digital therapeutic designed to reduce distress across the cancer trajectory. Methods: This nationwide waitlist randomized controlled trial in Germany enrolled patients with cancer across all tumor entities diagnosed within the last 5 years. Participants were randomized into the intervention (Mika plus usual care) and control (usual care alone) groups. The participants completed web-based assessments at baseline and at 2, 6, and 12 weeks. The primary outcome was the change in distress from baseline to week 12, as measured by the National Comprehensive Cancer Network Distress Thermometer. Secondary outcomes included depression, anxiety (Hospital Anxiety and Depression Scale), fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue), and quality of life (Clinical Global Impression-Improvement Scale). Intention-to-treat and per-protocol analyses were performed. Analyses of covariance were used to test for outcome changes over time between the groups, controlling for baseline. Results: A total of 218 patients (intervention: n=99 and control: n=119) were included in the intention-to-treat analysis. Compared with the control group, the intervention group reported greater reductions in distress (P=.03; ηp²=0.02), depression (P<.001; ηp²=0.07), anxiety (P=.03; ηp²=0.02), and fatigue (P=.04; ηp²=0.02). Per-protocol analyses revealed more pronounced treatment effects, with the exception of fatigue. No group difference was found for quality of life. Conclusions: Mika effectively diminished distress in patients with cancer. As a digital therapeutic solution, Mika offers accessible, tailored psychosocial and self-management support to address the unmet needs in cancer care. Trial Registration: German Clinical Trials Register (DRKS) DRKS00026038; https://drks.de/search/en/trial/DRKS00026038
- Open Access
- 8 February 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (4) , 435
Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4)
As cancer patients often suffer from fear of cancer progression (FoP), valid screening for FoP is of high relevance. The aims of this study were to test psychometric properties of two FoP questionnaires, to determine their relationship to other anxiety-related constructs, and to analyze the impact of sociodemographic and clinical factors on the FoP. Our sample consisted of n = 1733 patients with mixed cancer diagnoses. For measuring FoP, the Fear of Progression questionnaire (FoP-Q-12) and the Concerns About Cancer Recurrence Questionnaire (CARQ-4) were used. The mean scores of the FoP-Q-12 and the CARQ-4 were 30.0 ± 10.4 and 16.1 ± 10.8, respectively, indicating relatively high levels of FoP. Both questionnaires showed excellent internal consistency coefficients, α = 0.895 and α = 0.915, respectively. The correlation between the two FoP questionnaires was r = 0.72. Female patients reported more FoP than male patients (d = 0.84 and d = 0.54, respectively). There was a nonlinear age dependency of FoP, with an increase found in the age range from 18 to 50 years and a decrease in the older age range. Radiation, chemotherapy, and antibody therapy, but not surgery, lead to an increase in FoP. Both questionnaires show good psychometric properties and can be recommended for use in an oncological routine. Female patients and patients in the middle-age range deserve special attention from healthcare providers.
- 8 February 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (4) , 435
Open AccessFear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4)
As cancer patients often suffer from fear of cancer progression (FoP), valid screening for FoP is of high relevance. The aims of this study were to test psychometric properties of two FoP questionnaires, to determine their relationship to other anxiety-related constructs, and to analyze the impact of sociodemographic and clinical factors on the FoP. Our sample consisted of n = 1733 patients with mixed cancer diagnoses. For measuring FoP, the Fear of Progression questionnaire (FoP-Q-12) and the Concerns About Cancer Recurrence Questionnaire (CARQ-4) were used. The mean scores of the FoP-Q-12 and the CARQ-4 were 30.0 ± 10.4 and 16.1 ± 10.8, respectively, indicating relatively high levels of FoP. Both questionnaires showed excellent internal consistency coefficients, α = 0.895 and α = 0.915, respectively. The correlation between the two FoP questionnaires was r = 0.72. Female patients reported more FoP than male patients (d = 0.84 and d = 0.54, respectively). There was a nonlinear age dependency of FoP, with an increase found in the age range from 18 to 50 years and a decrease in the older age range. Radiation, chemotherapy, and antibody therapy, but not surgery, lead to an increase in FoP. Both questionnaires show good psychometric properties and can be recommended for use in an oncological routine. Female patients and patients in the middle-age range deserve special attention from healthcare providers.
- 19 January 2024
- Published by Wiley in Psycho-Oncology
- Vol. 33 (1) , e6282
Changes and predictors of social support in adolescent and young adult cancer survivors—Results of a 7‐year longitudinal study
Objective: As social support has been shown to have beneficial effects on coping with cancer, our study aims to close the research gap on perceived social support in adolescent and young adult (AYA) cancer survivors.Methods: AYAs evaluated their perceived positive social support (PS) and detrimental interactions (DI) by completing the Illness‐Specific Social Support Scale (ISSS‐8) upon completion of acute treatment (t1) as well as 1 year (t2) and 7 years (t6) later. Temporal changes of social support were examined. Sociodemographic, psychological and medical factors were investigated as predictors for PS and DI by using mixed effects models.Results: We analyzed data from 319 cancer survivors (74.9% women). At baseline, survivors reported an average score of 13.73 (SD = 2.52) for PS and 3.92 (SD = 2.85) for DI. Average perceived PS changed over time, while DI remained stable. Males, AYAs without a partner and AYAs with clinically meaningful anxiety or depression levels reported fewer PS. Higher effort to cope with the disease and clinically significant anxiety and depression levels were associated with more perceived DI.Conclusions: Existing social networks and perceived social support should be evaluated regularly in AYA‐cancer survivorship. The identification and discussion of mental health of AYAs should also be a standard component in survivor consultations both during treatment and follow‐up care, as elevated depression and anxiety levels were associated with fewer PS and more perceived DI.
- 19 January 2024
- Published by Wiley in Psycho-Oncology
- Vol. 33 (1) , e6282
Changes and predictors of social support in adolescent and young adult cancer survivors—Results of a 7‐year longitudinal study
Objective: As social support has been shown to have beneficial effects on coping with cancer, our study aims to close the research gap on perceived social support in adolescent and young adult (AYA) cancer survivors.Methods: AYAs evaluated their perceived positive social support (PS) and detrimental interactions (DI) by completing the Illness‐Specific Social Support Scale (ISSS‐8) upon completion of acute treatment (t1) as well as 1 year (t2) and 7 years (t6) later. Temporal changes of social support were examined. Sociodemographic, psychological and medical factors were investigated as predictors for PS and DI by using mixed effects models.Results: We analyzed data from 319 cancer survivors (74.9% women). At baseline, survivors reported an average score of 13.73 (SD = 2.52) for PS and 3.92 (SD = 2.85) for DI. Average perceived PS changed over time, while DI remained stable. Males, AYAs without a partner and AYAs with clinically meaningful anxiety or depression levels reported fewer PS. Higher effort to cope with the disease and clinically significant anxiety and depression levels were associated with more perceived DI.Conclusions: Existing social networks and perceived social support should be evaluated regularly in AYA‐cancer survivorship. The identification and discussion of mental health of AYAs should also be a standard component in survivor consultations both during treatment and follow‐up care, as elevated depression and anxiety levels were associated with fewer PS and more perceived DI.